Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), Innate Pharma SA (OtherIPHYF) and Neumora Therapeutics, Inc. (NMRA)
TipRanksApr 17 04:10 ET
Innate Pharma Analyst Ratings
BenzingaApr 11 07:34 ET
Innate Pharma SA: A Balanced Hold Rating Amidst Clinical Setbacks and Cautious Optimism
TipRanksMar 26 16:45 ET
Analysts Offer Insights on Healthcare Companies: Innate Pharma SA (OtherIPHYF), Medios AG (OtherMEDOF) and Tecan Group AG (OtherTCHBF)
TipRanksMar 22 21:40 ET
Innate Pharma Analyst Ratings
BenzingaMar 22 06:18 ET
Innate Pharma SA (IPHYF) Receives a Hold From Kepler Capital
TipRanksFeb 3 20:35 ET
Analysts Conflicted on These Healthcare Names: Innate Pharma SA (OtherIPHYF), Amgen (AMGN) and Regeneron (REGN)
TipRanksJan 5 20:50 ET
Analysts Offer Insights on Healthcare Companies: Arcellx Inc (ACLX) and Innate Pharma SA (OtherIPHYF)
TipRanksJan 4 06:10 ET
Analysts Offer Insights on Healthcare Companies: Innate Pharma SA (OtherIPHYF) and Medios AG (OtherMEDOF)
TipRanksNov 15, 2023 20:40 ET
HC Wainwright & Co. Reiterates Buy on Innate Pharma, Maintains $11.5 Price Target
BenzingaNov 15, 2023 08:27 ET
Innate Pharma Analyst Ratings
BenzingaNov 15, 2023 08:26 ET
Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Innate Pharma (IPHA) and Shockwave Medical (SWAV)
TipRanksOct 25, 2023 02:21 ET
Kepler Capital Reaffirms Their Hold Rating on Innate Pharma SA (IPHYF)
TipRanksOct 6, 2023 21:36 ET
HC Wainwright & Co. Reiterates Buy on Innate Pharma, Maintains $11.5 Price Target
BenzingaSep 18, 2023 06:48 ET
Innate Pharma Analyst Ratings
BenzingaSep 18, 2023 06:47 ET
Analysts Are Bullish on These Healthcare Stocks: Argenx Se (ARGX), Innate Pharma (IPHA)
TipRanksSep 18, 2023 06:32 ET
Analysts Are Neutral on These Healthcare Stocks: Demant (WILLF), Innate Pharma SA (IPHYF)
TipRanksSep 15, 2023 21:40 ET
Analysts Conflicted on These Healthcare Names: Clinuvel Pharmaceuticals Limited (OtherCLVLF), Medibank Private Ltd. (OtherMDBPF) and Innate Pharma SA (OtherIPHYF)
TipRanksJun 28, 2023 21:40 ET
Kepler Capital Reaffirms Their Hold Rating on Innate Pharma SA (IPHYF)
TipRanksJun 17, 2023 21:45 ET
HC Wainwright & Co. Reiterates Buy on Innate Pharma, Maintains $11.5 Price Target
BenzingaJun 16, 2023 06:59 ET
No Data
No Data